Neurology denials and appeals: the recurring patterns.
Neurology denies at roughly 18% by industry reporting, against a 5–10% average across most other specialties — nearly double, and it isn't one cause. It's five recurring patterns stacked on top of each other: medical necessity gaps, bundling errors, missing prior authorization, wrong or missing component modifiers, and documentation that doesn't name what the study actually found. This guide pairs each one with the exact CARC, the specific LCD or article to cite, the appeal argument when the claim was right, and the upstream fix that keeps it from happening again.
Key takeaways
- Missing or expired prior auth (CO-197/CO-15) is neurology's single biggest denial driver — bigger than medical necessity or bundling — and it's almost never appealable after the fact. The fix is entirely upstream, at scheduling.
- A CO-50 appeal that doesn't name the specific LCD by ID and MAC rarely succeeds. "Per CMS" or "medically necessary" with nothing else attached is the most common reason a winnable appeal fails on its first submission.
- CO-97 bundling denials on EMG are almost always the standalone-vs-add-on code confusion — 95860–95864 billed alongside a same-day NCS instead of 95885–95887. Check the NCCI modifier indicator before writing the appeal.
- CO-16 in this specialty is almost always a naming problem, not a missing document. Nerves, muscles, and injection sites have to be named individually in the note — a summary line doesn't support the code billed.
Why neurology denies at nearly double the industry rate
The 18% figure isn't a single failure point — it's five ordinary billing problems that happen to all land on the same specialty at once. EMG/NCS and EEG carry dense NCCI bundling because so many components overlap in one session. Botox, advanced imaging, and extended video-EEG carry heavy prior-authorization requirements that most other specialties don't stack this many of at once. Stroke, MS, epilepsy, and migraine coverage policy enforces diagnosis specificity as a hard gate, not a formality. And documentation for nerve-, muscle-, and injection-site-level work has to name specifics that a generic note skips. None of these is unique to neurology on its own — the combination, hitting nearly every high-volume code family in the specialty, is what pushes the average up.
| Denial | Why it fires | Cite by name | Appeal argument (if correct) | Prevention |
|---|---|---|---|---|
| CO-50 Not medically necessary | Diagnosis on the claim isn't on the MAC's covered list for that service | The specific LCD/article ID and MAC — e.g. Botulinum Toxin Injections L39836 (Palmetto GBA) or MRI/CT of the Head and Neck L37373 (Noridian) | Name the exact policy, the covered diagnosis or clinical threshold it establishes, and attach the note that documents it | Surface the coverage requirement at order entry, before the study or injection happens |
| CO-97 Bundled into another service | Code is a Column 2 component of a code already paid same date — most often the EMG standalone/add-on mix-up | The relevant NCS/EMG billing-and-coding article by MAC — e.g. A54969 (Noridian) or A56619 (Palmetto) | Only if the pair's modifier indicator is 1, not 0 — then document the second service as genuinely separate | Confirm same-day NCS status before choosing the EMG code family |
| CO-197 / CO-15 Missing or expired prior auth | Botox, advanced imaging, or extended video-EEG billed without current authorization — neurology's single biggest denial driver | The payer's own prior-auth policy for that CPT code, plan type, and date of service | Rarely winnable unless the requirement genuinely didn't apply — verify before appealing | Confirm authorization by payer and plan type at scheduling, every time, no exceptions for "usually doesn't need it" |
| CO-4 Modifier missing or invalid | 26 or TC absent or wrong for the site of service on EEG or EMG/NCS | N/A — a component-split correction, not a coverage dispute | Rebill with the correct component modifier; this is a correction, not an appeal, almost every time | Map every diagnostic study to its default component split by location in the charge master |
| CO-16 Missing or incomplete information | Note doesn't name the specific nerves, muscles, or injection sites the code requires | N/A — a documentation correction, not a coverage dispute | Resubmit once the record actually supports the code; not a contested denial once fixed | Build named-nerve, named-muscle, and named-injection-site fields directly into the documentation template |
CO-50: cite the policy, not "medical necessity"
This is the denial where the claim is most often clinically correct and administratively wrong. The physician's reasoning was sound; the diagnosis on the claim simply didn't match what the MAC's coverage document lists as supporting that specific service. Three categories carry most of the volume in neurology, and each needs its own citation, not a generic one.
- 1Botox for chronic migraine. Cite the current Botulinum Toxin Injections LCD by MAC and ID:
L39836(Palmetto GBA),L39857(CGS Administrators),L35172/L35170(Noridian Healthcare Solutions),L39832(Wellpoint Federal),L39909(WPS Insurance Corporation),L38809(Novitas Solutions), orL33274(First Coast Service Options) — confirmed live against the CMS Coverage Database. Pair the citation with the chronic-migraine threshold the chart supports: 15 or more headache days per month, at least 8 meeting migraine criteria, sustained 3 months, using a specific code likeG43.719(chronic migraine without aura, intractable) rather than an unspecified one. - 2Advanced imaging — MRI brain or spine. Cite Noridian's current MRI and CT Scans of the Head and Neck LCD,
L37373(effective 10/23/2025, superseding retiredL35175), or its current Lumbar MRI LCD,L34220(also effective 10/23/2025, superseding retiredL37281) — both confirmed live. Pair it with the exam findings or red-flag symptoms that justify imaging, coded specifically:M54.16(lumbar radiculopathy) supports a spine MRI order far better thanM54.50(unspecified low back pain), and a symptom-only code likeR51.9(headache, unspecified) rarely clears a repeat brain MRI without a more specific neurologic finding attached. - 3EEG and video-EEG. Where the MAC publishes a specific EEG coverage document — Palmetto GBA's Special Electroencephalography LCD,
L33447, is the clearest example — cite it directly rather than a generic EEG denial response. A seizure-frequency or intractability code (G40.911, epilepsy unspecified, intractable, with status epilepticus) supports repeat or extended monitoring in a way a bare, non-intractable code doesn't.
⚠️ The LCD and article IDs, MAC names, and effective/retirement dates above were confirmed live against the CMS Coverage Database. The full covered-diagnosis lists and frequency limits inside each document were not independently re-verified in this build (CMS's own article and LCD pages blocked automated retrieval), so pull the specific document text before finalizing an appeal letter or an order-set rule against it.
CO-97: confirm the indicator before you argue distinctness
Neurology's most common bundling pattern is the EMG family mix-up: a standalone extremity EMG code (95860–95864) billed on the same date as a nerve conduction study, when the add-on codes (95885–95887) were the correct choice because the two were performed the same session. The payer's system reads it as reporting the same needle-exam work twice under two different rule sets, and it denies as bundled.
Before writing any appeal, look up the NCCI modifier indicator for the specific pair. An indicator of 0 means no modifier, however well documented, changes the outcome — the second code simply isn't separately payable, and staff time is better spent elsewhere. An indicator of 1 means 59 or the specific X-modifier (XS for separate structure covers most defensible neurology unbundling, since it's usually a distinct nerve or muscle group) can override it, but only where the note independently documents the distinction. The current NCS/EMG billing-and-coding article for your jurisdiction — A54969 (Noridian), A56619 (Palmetto GBA), A54095 (Novitas Solutions), A57478 (WPS Insurance Corporation), A57668 (Wellpoint Federal), A57307 (CGS Administrators), or A57123 (First Coast Service Options), all confirmed live — is the document to cite alongside the operative note.
Run the indicator check before the appeal, not after a denial comes back a second time. An MAI or modifier-indicator lookup takes a few minutes; writing and tracking an appeal that had no path to begin with costs a lot more, and it delays the claims that actually are winnable.
CO-197 / CO-15: the one you prevent, not the one you fight
This is neurology's largest denial driver by volume, and it's structurally different from the other four: once the claim denies, there is almost no path back. Botox for chronic migraine, MRI brain or spine, EMG/NCS under a growing share of commercial plans, and video-EEG monitoring extending past 24–48 hours are the four categories that generate most of this denial family. Unlike a coding or bundling error, a missing authorization isn't something documentation fixes after the fact — the payer's system already recorded that no auth was on file at the time of service, and most payer policies simply do not permit retroactive approval regardless of how medically necessary the service turns out to have been.
The exception worth checking before writing off an appeal entirely: confirm the requirement actually applied to that specific payer, plan type, and CPT code before assuming the denial is correct. Traditional Medicare generally does not require prior auth for outpatient EMG/NCS or routine EEG, for example, while a Medicare Advantage plan covering the same patient might. If the authorization requirement genuinely didn't apply, that's a winnable argument. Outside that narrow case, the only real fix is upstream: verify authorization by payer and plan type at scheduling, every time, and build a hard stop into the workflow rather than relying on staff memory for which plans usually don't need it.
CO-4 and CO-16: corrections, not appeals
These two denials get treated like disputes when they're almost always corrections. A CO-4 on an EEG or EMG/NCS claim usually means the 26 or TC component modifier is missing or doesn't match the site of service — the fix is rebilling with the correct modifier, not building a case. A CO-16 in neurology is almost always a naming problem: "bilateral upper extremity NCS" without median, ulnar, and radial named individually by side doesn't support the nerve count billed, the same way "complete EMG study" without the specific muscles listed doesn't support a 95886 unit count, and a Botox claim without a per-site injection breakdown doesn't support the PREEMPT-protocol documentation payers increasingly check against. Fix the note, resubmit, and move on — but also fix the template that let the gap through in the first place, or the same denial repeats on the next claim.
Do and don't
- Name the specific LCD or article by ID and MAC in every CO-50 appeal — never "per CMS" alone.
- Check the NCCI modifier indicator before writing a CO-97 appeal; stop if it's 0.
- Verify prior-auth requirements by payer and plan type at scheduling, before the study or injection, not after billing.
- Build named-nerve, named-muscle, and named-injection-site fields into the documentation template itself.
- Don't submit a medical necessity appeal that argues in the abstract without naming the covered diagnosis a specific policy requires.
- Don't write a bundling appeal before confirming the pair's modifier indicator even allows one.
- Don't assume a prior-auth denial is appealable just because the service was medically necessary.
- Don't treat a CO-4 or CO-16 denial as a fight — they're corrections, and treating them as disputes just delays the resubmission.
Fighting the same neurology denials every month?
We'll audit a sample of your recent neurology denials, name the specific LCD gaps and bundling patterns behind them, and show what's actually recoverable versus what to stop appealing.
Frequently asked questions
What's the fastest way to know whether a CO-97 bundling denial in neurology is even worth appealing?
Look up the NCCI modifier indicator for the specific code pair before you do anything else. An indicator of 0 means the edit cannot be bypassed by any modifier, however well the chart documents distinctness — appealing wastes staff time. An indicator of 1 means a 59 or X-modifier can override it if the record genuinely shows a separate nerve, muscle group, session, or structure. In neurology this shows up most on the EMG add-on codes (95885–95887) billed against a standalone EMG code (95860–95864) for the same date — confirm which family the claim should have used before writing anything.
Can we appeal a neurology prior authorization denial after the service was already performed?
Rarely, and only in narrow circumstances. If the payer's own policy didn't actually require prior auth for that specific CPT code, plan type, and date of service, that's a winnable argument — verify it against the payer's current policy before assuming the denial is wrong. Outside that, most payers will not retroactively authorize a service performed without one, regardless of medical necessity, which is why CO-197/CO-15 denials in neurology are prevented upstream at scheduling, not fought after the fact. A same-day peer-to-peer, before the study or injection is performed, is the only reliable way to convert a denial risk into an approval once authorization is in question.
What actually has to be in a neurology medical necessity appeal for it to work?
Three things, named specifically: the exact LCD or article by ID and MAC — not "per CMS" — the specific covered diagnosis or clinical threshold the chart supports under that policy, and the clinical documentation establishing it in the patient's own words and exam findings, not a summary line. A generic appeal that argues medical necessity in the abstract, without naming the policy it's being measured against, is the single most common reason a winnable neurology appeal fails on the first submission.
Verify before billing. CPT is a registered trademark of the American Medical Association; codes here are paraphrased, not reproduced from the CPT Professional edition. CPT, HCPCS and ICD-10 codes, coverage policy, and bundling edits change, including annual code-set updates. This page reflects standard industry practice and is provided for general education — it is not a substitute for your own compliance review, your current payer contracts, or the current-year code sets. Confirm requirements against your specific payer mix before submitting claims.